Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Mediators of Inflammation, enter your email address in the box below.

Mediators of Inflammation
Volume 2013, Article ID 438653, 10 pages
http://dx.doi.org/10.1155/2013/438653
Research Article

A Plasma Proteomic Approach in Rett Syndrome: Classical versus Preserved Speech Variant

Alessio Cortelazzo,1,2 Roberto Guerranti,1 Claudio De Felice,3 Cinzia Signorini,4 Silvia Leoncini,2,4 Alessandra Pecorelli,2,4 Claudia Landi,5 Luca Bini,5 Barbara Montomoli,2 Claudia Sticozzi,6 Lucia Ciccoli,4 Giuseppe Valacchi,6,7 and Joussef Hayek2

1Department of Medical Biotechnologies, University of Siena, Via A. Moro 2, 53100 Siena, Italy
2Child Neuropsychiatry Unit, University Hospital Azienda Ospedaliera Universitaria Senese (AOUS), Viale M. Bracci 16, 53100 Siena, Italy
3Neonatal Intensive Care Unit, University Hospital AOUS, Viale M. Bracci 16, 53100 Siena, Italy
4Department of Molecular and Developmental Medicine, University of Siena, Via A. Moro 6, 53100 Siena, Italy
5Department of Life Science, University of Siena, Via A. Moro 2, 53100 Siena, Italy
6Department of Life Sciences and Biotechnology, University of Ferrara, Via Borsari 46, 44100 Ferrara, Italy
7Department of Food and Nutrition, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea

Received 19 September 2013; Revised 16 October 2013; Accepted 17 October 2013

Academic Editor: Paul Ashwood

Copyright © 2013 Alessio Cortelazzo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Chahrour and H. Y. Zoghbi, “The story of Rett Syndrome: from clinic to neurobiology,” Neuron, vol. 56, no. 3, pp. 422–437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. L. Neul, W. E. Kaufmann, D. G. Glaze et al., “Rett syndrome: revised diagnostic criteria and nomenclature,” Annals of Neurology, vol. 68, no. 6, pp. 944–950, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. E. Amir, I. B. Van Den Veyver, M. Wan, C. Q. Tran, U. Francke, and H. Y. Zoghbi, “Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2,” Nature Genetics, vol. 23, no. 2, pp. 185–188, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Mari, S. Azimonti, I. Bertani et al., “CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome,” Human Molecular Genetics, vol. 14, no. 14, pp. 1935–1946, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Ariani, G. Hayek, D. Rondinella et al., “FOXG1 is responsible for the congenital variant of rett syndrome,” American Journal of Human Genetics, vol. 83, no. 1, pp. 89–93, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Oexle, B. Thamm-Mücke, T. Mayer, and S. Tinschert, “Macrocephalic mental retardation associated with a novel C-terminal MECP2 frameshift deletion,” European Journal of Pediatrics, vol. 164, no. 3, pp. 154–157, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Zappella, I. Meloni, I. Longo, G. Hayek, and A. Renieri, “Preserved speech variants of the Rett syndrome: molecular and clinical analysis,” American Journal of Medical Genetics, vol. 104, no. 1, pp. 14–22, 2001. View at Google Scholar
  8. V. Matarazzo and G. V. Ronnett, “Temporal and regional differences in the olfactory proteome as a consequence of MeCP2 deficiency,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 20, pp. 7763–7768, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Grillo, C. Lo Rizzo, L. Bianciardi et al., “Revealing the complexity of a monogenic disease: rett syndrome exome sequencing,” PLoS ONE, vol. 8, no. 2, Article ID e56599, 2013. View at Google Scholar
  10. A. Bebbington, A. Anderson, D. Ravine et al., “Investigating genotype-phenotype relationships in Rett syndrome using an international data set,” Neurology, vol. 70, no. 11, pp. 868–875, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Artuso, F. T. Papa, E. Grillo et al., “Investigation of modifier genes within copy number variations in Rett syndrome,” Journal of Human Genetics, vol. 56, no. 7, pp. 508–515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Scala, I. Longo, F. Ottimo et al., “MECP2 deletions and genotype-phenotype correlation in Rett syndrome,” American Journal of Medical Genetics A, vol. 143, no. 23, pp. 2775–2784, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Renieri, F. Mari, M. A. Mencarelli et al., “Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant),” Brain and Development, vol. 31, no. 3, pp. 208–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Görg, C. Obermaier, G. Boguth et al., “The current state of two-dimensional electrophoresis with immobilized pH gradients,” Electrophoresis, vol. 21, no. 6, pp. 1037–1053, 2000. View at Google Scholar
  15. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  16. J. Penders and J. R. Delanghe, “Alpha 1-microglobulin: clinical laboratory aspects and applications,” Clinica Chimica Acta, vol. 346, no. 2, pp. 107–118, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Poon, S. B. Easterbrook-Smith, M. S. Rybchyn, J. A. Carver, and M. R. Wilson, “Clusterin is an ATP—independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state,” Biochemistry, vol. 39, no. 51, pp. 15953–15960, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Van Vlierberghe, M. Langlois, and J. Delanghe, “Haptoglobin polymorphisms and iron homeostasis in health and in disease,” Clinica Chimica Acta, vol. 345, no. 1-2, pp. 35–42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Kamath and G. Y. H. Lip, “Fibrinogen: biochemistry, epidemiology and determinants,” QJM, vol. 96, no. 10, pp. 711–729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. J. P. Nicholson, M. R. Wolmarans, and G. R. Park, “The role of albumin in critical illness,” British Journal of Anaesthesia, vol. 85, no. 4, pp. 599–610, 2000. View at Google Scholar · View at Scopus
  21. K. Kett, P. Brandtzaeg, and O. Fausa, “J-Chain expression is more prominent in immunoglobulin A2 than in immunolgobulin A1 colonic immunocytes and is decreased in both subclasses associated with inflammatory bowel disease,” Gastroenterology, vol. 94, no. 6, pp. 1419–1425, 1988. View at Google Scholar · View at Scopus
  22. R. D. Kidd, J. E. Russell, N. J. Watmough, E. N. Baker, and T. Brittain, “The role of β chains in the control of the hemoglobin oxygen binding function: chimeric human/mouse proteins, structure, and function,” Biochemistry, vol. 40, no. 51, pp. 15669–15675, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. R. W. Carrell, “α1-antitrypsin: molecular pathology, leukocytes, and tissue damage,” Journal of Clinical Investigation, vol. 78, no. 6, pp. 1427–1431, 1986. View at Google Scholar · View at Scopus
  24. P. G. Shackelford, S. H. Polmar, and J. L. Mayus, “Spectrum of IgG2 subclass deficiency in children with recurrent infections: prospective study,” Journal of Pediatrics, vol. 108, no. 5, pp. 647–653, 1986. View at Google Scholar · View at Scopus
  25. D. A. Loeffler, J. R. Connor, P. L. Juneau et al., “Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions,” Journal of Neurochemistry, vol. 65, no. 2, pp. 710–716, 1995. View at Google Scholar · View at Scopus
  26. M. R. Daha, “Role of complement in innate immunity and infections,” Critical Reviews in Immunology, vol. 30, no. 1, pp. 47–52, 2010. View at Google Scholar · View at Scopus
  27. A. M. Johnson, G. Merlini, J. Sheldon, and K. Ichihara, “Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition—international federation of clinical chemistry and laboratory medicine (IFCC): IFCC scientific division committee on plasma proteins (C-PP),” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 3, pp. 419–426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Mortz, T. N. Krogh, H. Vorum, and A. Görg, “Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis,” Proteomics, vol. 1, no. 11, pp. 1359–1363, 2001. View at Google Scholar · View at Scopus
  29. U. Hellman, C. Wernstedt, J. Gonez, and C.-H. Heldin, “Improvement of an “in-ge” digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing,” Analytical Biochemistry, vol. 224, no. 1, pp. 451–455, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. N. L. Anderson, N. G. Anderson, T. W. Pearson et al., “A human proteome detection and quantitation project,” Molecular and Cellular Proteomics, vol. 8, no. 5, pp. 883–886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Archer, J. Evans, H. Leonard et al., “Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation,” Journal of Medical Genetics, vol. 44, no. 2, pp. 148–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. J. L. Neul, P. Fang, J. Barrish et al., “Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome,” Neurology, vol. 70, no. 16, pp. 1313–1321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Satoi, “Developmental aspects of cerebrospinal fluid levels of β-phenylethylamine and it's role in pediatric neurological disorders,” Kurume Medical Journal, vol. 46, no. 1, pp. 17–23, 1999. View at Google Scholar · View at Scopus
  34. C. De Felice, G. Guazzi, M. Rossi et al., “Unrecognized lung disease in classic Rett syndrome: a physiologic and high-resolution CT imaging study,” Chest, vol. 138, no. 2, pp. 386–392, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Schwartzman, M. R. Vítolo, J. S. Schwartzman, and M. B. De Morais, “Eating practices, nutritional status and constipation in patients with Rett syndrome,” Arquivos de Gastroenterologia, vol. 45, no. 4, pp. 284–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. N. C. Derecki, J. C. Cronk, Z. Lu et al., “Wild-type microglia arrest pathology in a mouse model of Rett syndrome,” Nature, vol. 484, no. 7392, pp. 105–109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. C. De Felice, L. Ciccoli, S. Leoncini et al., “Systemic oxidative stress in classic Rett syndrome,” Free Radical Biology and Medicine, vol. 47, no. 4, pp. 440–448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Chauhan and V. Chauhan, “Oxidative stress in autism,” Pathophysiology, vol. 13, no. 3, pp. 171–181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. H. Sadrzadeh and J. Bozorgmehr, “Haptoglobin phenotypes in health and disorders,” American Journal of Clinical Pathology, vol. 121, pp. 97–104, 2004. View at Google Scholar · View at Scopus
  40. H. V. Aposhian, R. A. Zakharyan, U. K. Chowdhury, and M. D. Avram, “Search for plasma protein biomarker for autism using differential in-gel electrophoresis,” Toxicological Sciences, vol. 90, no. 1, p. 23, 2006. View at Google Scholar
  41. E. J. Pavón, P. Muñoz, A. Lario et al., “Proteomic analysis of plasma from patients with systemic lupus erythematosus: increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms,” Proteomics, vol. 6, pp. S282–292, 2006. View at Google Scholar · View at Scopus
  42. R. Guerranti, E. Bertocci, A. Fioravanti et al., “Serum proteome of patients with systemic sclerosis: molecular analysis of expression and prevalence of haptoglobin alpha chain isoforms,” International Journal of Immunopathology and Pharmacology, vol. 23, no. 3, pp. 901–909, 2010. View at Google Scholar · View at Scopus
  43. D. W. Cooke, S. Naidu, L. Plotnick, and G. D. Berkovitz, “Abnormalities of thyroid function and glucose control in subjects with Rett syndrome,” Hormone Research, vol. 43, no. 6, pp. 273–278, 1995. View at Google Scholar · View at Scopus
  44. P. Huppke, C. Roth, H. J. Christen, K. Brockmann, and F. Hanefeld, “Endocrinological study on growth retardation in Rett syndrome,” Acta Paediatrica, vol. 90, no. 11, pp. 1257–1261, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. H.-J. Chiu, D. A. Fischman, and U. Hammerling, “Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation,” FASEB Journal, vol. 22, no. 11, pp. 3878–3887, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Signorini, C. De Felice, S. Leoncini et al., “F4-neuroprostanes mediate neurological severity in Rett syndrome,” Clinica Chimica Acta, vol. 412, no. 15-16, pp. 1399–1406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Leoncini, C. de Felice, C. Signorini et al., “Oxidative stress in Rett syndrome: natural history, genotype, and variants,” Redox Report, vol. 16, no. 4, pp. 145–153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. C. De Felice, C. Signorini, T. Durand et al., “Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil,” Genes and Nutrition, vol. 7, no. 3, pp. 447–458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Ciccoli, C. De Felice, E. Paccagnini et al., “Morphological changes and oxidative damage in Rett Syndrome erythrocytes,” Biochimica et Biophysica Acta, vol. 1820, no. 4, pp. 511–520, 2012. View at Publisher · View at Google Scholar · View at Scopus